-
Signature
-
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Neil F. McFarlane
-
Issuer symbol
-
ZVRA
-
Transactions as of
-
10 Oct 2025
-
Net transactions value
-
-$210,908
-
Form type
-
4
-
Filing time
-
10 Oct 2025, 19:17:35 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| McFarlane Neil F. |
President and CEO, Director |
C/O ZEVRA THERAPEUTICS, INC., 1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION |
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Neil F. McFarlane |
10 Oct 2025 |
0001681098 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ZVRA |
Common Stock |
Options Exercise |
|
+50,000 |
+26% |
|
241,516 |
10 Oct 2025 |
Direct |
F1 |
| transaction |
ZVRA |
Common Stock |
Sale |
$210,908 |
-19,500 |
-8.1% |
$10.82 |
222,016 |
10 Oct 2025 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ZVRA |
Restricted Stock Unit |
Options Exercise |
$0 |
-50,000 |
-33% |
$0.000000 |
100,000 |
10 Oct 2025 |
Common Stock |
50,000 |
$0.000000 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: